Moreover, the findings, if replicated in his and others» ongoing studies, could spur development of drugs that target
HDL subclasses, working to raise HDL without apoC - III and lower HDL with it.
Sacks says the techniques his team used to measure the levels of the two
HDL subclasses, which Harvard is patenting, could lead to more precise tests to evaluate heart disease risk and treatment response.
Advanced Lipoprotein Analysis (VAP by Atherotec): this test goes beyond the routine cholesterol panel (
HDL, calculated LDL, triglycerides, and total cholesterol), by providing measurements of
HDL, LDL, and VLDL (very low - density lipoprotein), and also measuring other important lipoprotein
subclasses, including Lp (a),
HDL subtypes, and IDL (intermediate - density lipoprotein).